Free Trial

Akoya Biosciences (AKYA) SEC Filings & 10K Form

$2.30
+0.33 (+16.75%)
(As of 05/28/2024 ET)

Recent Akoya Biosciences SEC Filings

DateFilerForm TypeView
04/23/2024
5:03 AM
Akoya Biosciences (Filer)
Form DEF 14A
04/23/2024
5:04 AM
Akoya Biosciences (Filer)
Form DEFA14A
04/23/2024
5:05 AM
Akoya Biosciences (Filer)
Form ARS
03/25/2024
4:14 PM
Akoya Biosciences (Issuer)
Ramachandran Niro Ph.D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:16 PM
Akoya Biosciences (Issuer)
Pla Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:12 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:51 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4/A
03/22/2024
4:54 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
4:56 PM
Akoya Biosciences (Subject)
McKelligon Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2024
7:40 PM
Akoya Biosciences (Issuer)
SHEPLER ROBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
7:41 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:15 PM
Akoya Biosciences (Subject)
McKelligon Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
5:01 AM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4/A
03/01/2024
8:58 PM
Akoya Biosciences (Issuer)
Ek John Frederick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
8:52 PM
Akoya Biosciences (Issuer)
Ramachandran Niro Ph.D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
8:52 PM
Akoya Biosciences (Issuer)
Pla Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
8:53 PM
Akoya Biosciences (Issuer)
Kamocsay Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
8:21 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
8:11 AM
Akoya Biosciences (Subject)
PSC Capital Partners LLC (Filed by)
Form SC 13G/A
01/08/2024
5:02 AM
Akoya Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
7:50 AM
Akoya Biosciences (Subject)
Schindel Yair Chaim (Filed by)
Form SC 13G/A
12/20/2023
6:16 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
3:24 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
5:33 PM
Akoya Biosciences (Subject)
McKelligon Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2023
4:40 PM
Akoya Biosciences (Issuer)
Kamocsay Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
4:41 PM
Akoya Biosciences (Issuer)
Pla Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
3:37 PM
Akoya Biosciences (Subject)
McKelligon Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/13/2023
4:10 PM
Akoya Biosciences (Subject)
Moy Marilee (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2023
5:28 PM
Akoya Biosciences (Subject)
Moy Marilee (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/28/2023
4:18 PM
Akoya Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
2:31 PM
Akoya Biosciences (Subject)
DRISCOLL JOSEPH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2023
5:16 PM
Akoya Biosciences (Subject)
DRISCOLL JOSEPH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2023
3:46 PM
Akoya Biosciences (Subject)
DRISCOLL JOSEPH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2023
6:18 AM
Akoya Biosciences (Subject)
Schindel Yair Chaim (Filed by)
Form SC 13G
06/12/2023
5:18 PM
Akoya Biosciences (Issuer)
Ek John Frederick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
5:15 PM
Akoya Biosciences (Issuer)
Raffin Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
5:16 PM
Akoya Biosciences (Issuer)
SHEPLER ROBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
5:16 PM
Akoya Biosciences (Issuer)
Winkler Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
5:17 PM
Akoya Biosciences (Issuer)
Mendel Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
5:18 PM
Akoya Biosciences (Issuer)
LAI GOLDMAN MYLA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
3:32 PM
Akoya Biosciences (Filer)
Form 424B5
New trading system called MSFT, NVDA & MSFT (Ad)

Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.

Just follow this link here!
06/07/2023
3:40 PM
Akoya Biosciences (Filer)
Form 424B5
06/06/2023
8:45 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:53 PM
Akoya Biosciences (Subject)
DRISCOLL JOSEPH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2023
3:33 PM
Akoya Biosciences (Subject)
McKelligon Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2023
4:54 PM
Akoya Biosciences (Issuer)
Winkler Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
4:36 PM
Akoya Biosciences (Issuer)
Nolan Garry Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
4:37 PM
Akoya Biosciences (Issuer)
SCHNETTLER THOMAS P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
4:37 PM
Akoya Biosciences (Issuer)
SHEPLER ROBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
4:38 PM
Akoya Biosciences (Issuer)
Mendel Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
4:38 PM
Akoya Biosciences (Issuer)
Raffin Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
4:13 PM
Akoya Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
4:49 PM
Akoya Biosciences (Subject)
DRISCOLL JOSEPH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AKYA) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners